1. Home
  2. EFC vs HROW Comparison

EFC vs HROW Comparison

Compare EFC & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EFC

Ellington Financial Inc.

HOLD

Current Price

$13.62

Market Cap

1.5B

Sector

Finance

ML Signal

HOLD

Logo Harrow Inc.

HROW

Harrow Inc.

HOLD

Current Price

$40.36

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EFC
HROW
Founded
2007
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.4B
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
EFC
HROW
Price
$13.62
$40.36
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
8
Target Price
$14.46
$68.86
AVG Volume (30 Days)
1.5M
683.4K
Earning Date
11-05-2025
11-10-2025
Dividend Yield
11.46%
N/A
EPS Growth
1.22
N/A
EPS
1.33
N/A
Revenue
$329,815,000.00
$250,042,000.00
Revenue This Year
N/A
$43.92
Revenue Next Year
$8.81
$41.22
P/E Ratio
$10.22
N/A
Revenue Growth
13.84
47.83
52 Week Low
$11.12
$20.85
52 Week High
$14.40
$50.72

Technical Indicators

Market Signals
Indicator
EFC
HROW
Relative Strength Index (RSI) 49.44 54.51
Support Level $13.30 $39.64
Resistance Level $14.04 $42.44
Average True Range (ATR) 0.20 2.24
MACD -0.02 0.35
Stochastic Oscillator 42.57 64.90

Price Performance

Historical Comparison
EFC
HROW

About EFC Ellington Financial Inc.

Ellington Financial Inc is a specialty finance company. Its primary investment objective is to generate attractive, risk-adjusted total returns for its shareholders by making investments. The company has two reportable segments; The Investment Portfolio Segment is focused on investing in a diverse array of financial assets, including residential and commercial mortgage loans, residential mortgage-backed securities, non-mortgage- and mortgage-related derivatives, debt and equity investments in loan origination companies, and other strategic investments, and The Longbridge Segment is focused on the origination and servicing of reverse mortgage loans. it acquires reverse mortgage loans both through its origination activities and through secondary market purchases.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

Share on Social Networks: